Activity

Activity ID

4524

Expires

October 10, 2022

Format Type

Journal-based CME

CME Credit

1

Fee

$30
CME Provider

JAMA

Description

This Medical Letter review summarizes prescription cannabinoid formulations derived from botanical marijuana available for clinical use and the supporting evidence for various indications.

doi:10.1001/jama.2016.11772

Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?
No

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

To review studies on Cannabis and Cannabinoids use in therapeutics.

Keywords

Substance Use and Addiction, Demyelinating Disorders, Epilepsy and Seizures, Multiple Sclerosis, Neurology

Competencies

Medical Knowledge

CME Credit Type

AMA PRA Category 1 Credit

Additional Information

doi:10.1001/jama.2016.11772

View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.